mRNA |
BRD8899 |
CTRPv2 |
pan-cancer |
AAC |
0.027 |
0.5 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.025 |
0.5 |
mRNA |
BRD-K37390332 |
CTRPv2 |
pan-cancer |
AAC |
0.027 |
0.5 |
mRNA |
tandutinib |
CTRPv2 |
pan-cancer |
AAC |
0.025 |
0.5 |
mRNA |
BRD-A05715709 |
CTRPv2 |
pan-cancer |
AAC |
0.042 |
0.5 |
mRNA |
BRD-K34222889 |
CTRPv2 |
pan-cancer |
AAC |
0.021 |
0.5 |
mRNA |
selumetinib:JQ-1 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.023 |
0.5 |
mRNA |
BRD-K17060750 |
CTRPv2 |
pan-cancer |
AAC |
0.025 |
0.5 |
mRNA |
BRD-A02303741:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.026 |
0.5 |
mRNA |
Teniposide |
CTRPv2 |
pan-cancer |
AAC |
0.026 |
0.5 |